Mono Pharmacare (NSE SME)
Aug 28, 2023 - Aug 30, 2023
| Price | ₹26 - ₹28 |
| Premium | ₹2 |
|---|---|
| Lot size | 4000 |
| Allotment | Sep 4, 2023 |
| Listing | Sep 7, 2023 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 4000 | 112000 | 0 |
| HNI | 2 | 8000 | 224000 | 0 |
Last updated on 30-Aug-2023 17:00:03
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 5,00,000 | 54,44,000 | 10.89 |
| NIB | 22,60,000 | 1,83,48,000 | 8.12 |
| RETAIL | 22,64,000 | 4,38,88,000 | 19.39 |
| Total | 50,24,000 | 6,76,80,000 | 13.47 |
| Retail Apps | 10,972 | © IPO Premium | |
Incorporated in 1994, Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products.
The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac - Diabetic medicines, and cosmocare products.
Mono Pharmacare works with contract manufacturers to manufacture pharmaceutical products to sell them under their brand name DLS Export. The company acquired DLS Export in 2022, for an aggregate consideration of ₹ 609 lakhs, in order to grow its product portfolio in selected therapeutic areas.
As on February 28, 2023, the company has over 168 pharmaceutical companies as their distributors and stockists and also, and served over 3,036 customers/vendors who are a mix of retail pharmacy stores as well as wholesalers.
Mono Pharmacare IPO Details
Mono Pharmacare IPO is a Book Built Issue. The IPO total issue size is Rs 15.40 Cr. The Mono Pharmacare IPO price is ₹26 to ₹28 per share. The IPO will list on NSE SME.
| Issue Size | 5,500,000 shares (aggregating up to ₹15.40 Cr) |
| Fresh Issue | 5,500,000 shares (aggregating up to ₹[.] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 12,368,564 |
| Share holding post issue | 17,868,564 |
| Market Maker portion | 276,000 shares |
Mono Pharmacare IPO Reservation
| QIB Shares Offered | Not more than 10.00% of the Net offer |
| NII (HNI) Shares Offered | Not less than 45.00% of the Offer |
| Retail Shares Offered | Not less than 45.00% of the Offer |
Mono Pharmacare IPO Lead Manager(s)
Unistone Capital Pvt Ltd
Company Financials
| Period | Mar 2020 | Mar 2021 | Mar 2022 |
| Assets | 871.70 | 1,122.46 | 1,438.31 |
| Revenue | 1,168.90 | 2,837.83 | 3,710.27 |
| Profit | 1.99 | 9.51 | 35.09 |
| Net Worth | 201.92 | 369.58 | 427.57 |
| Reserves | |||
| Borrowing | 633.46 | 608.03 | 643.93 |
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html